Asia-Pacific Bio Pharmaceuticals market by Product Type (Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte colony-stimulating factor (G-CSF), Interferon and Human growth hormones (HGH)) by Therapeutic Type (Neurology, Infectious diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Bio Pharmaceuticals market by Product Type (Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte colony-stimulating factor (G-CSF), Interferon and Human growth hormones (HGH)) by Therapeutic Type (Neurology, Infectious diseases, Diabetes, Oncology, Cardiovascular and Other Therapeutic Areas), and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 636 | Pages: 142 | October 2016 | Region: Asia Pacific


The Asia-Pacific Bio Pharmaceuticals market was worth $30.67 billion in 2016 and estimated to be growing at a CAGR of 10.05%, to reach $49.5 billion by 2021. Asia Pacific is the third largest pharmaceutical market in the world after North America and Europe. Major driver for the pharmaceutical industry in this region is generics, aided by factors such as the aging population and impending expiry of patented drugs.

Biopharmaceuticals are medical drugs which can either be produces by biotechnological techniques like recombinant DNA technology or from transgenic plants and animals that are genetically modified. Various diseases such as cancer, diabetes, rheumatoid arthritis, cardiovascular diseases and chronic renal failure are being treated by biopharmaceutical drugs which were non curable with earlier molecular drugs.

Major factors such as technological advancements in biopharmaceuticals, increasing geriatric population, increasing research and development investment and rising incidences of chronic diseases are propelling the market growth. In addition, the ability of biopharmaceuticals to approach a specific target with high efficiency helps in the treatment of various chronic diseases and disorders. However, risk of side-effects and high cost of biopharmaceuticals are restraining the growth of the market.

The Asia-Pacific bio pharmaceuticals market is segmented on the basis of products into Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte colony-stimulating factor (G-CSF), Interferon and Human growth hormones (HGH). Monoclonal antibodies segment holds the highest number of shares in the product sector. Based on therapeutics, the market is bifurcated into Neurology, Infectious diseases, Diabetes, Oncology, Cardiovascular and other therapeutic areas. In terms of therapeutic application, oncology is the largest segment in the biopharmaceuticals market.

Based on geography the market is analysed under various regions namely, China, India, Japan, South Korea and Australia. China leads the market in this region due to highest number of population.

Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc., and Novartis AG are some of the leading players in the market for biopharmaceuticals.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Monoclonal Antibodies (mAb)       

                                5.1.2 Erythropoietin       

                                5.1.3 Biotech Vaccines  

                                5.1.4 Recombinant Human (RH) Insulin 

                                5.1.5 Granulocyte colony-stimulating factor (G-CSF)       

                                5.1.6 Interferon               

                                5.1.7 Human growth hormones (HGH)  

                5.2 By Therapeutic Type                               

                                5.2.1 Neurology               

                                5.2.2 Infectious diseases              

                                5.2.3 Diabetes  

                                5.2.4 Oncology 

                                5.2.5 Cardiovascular       

                                5.2.6 Other Therapeutic Areas  

6. Geographical Analysis                                              

                6.3 Asia-Pacific                 

                                6.1 Introduction               

                                6.2 China             

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea               

                                6.6 Australia      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Merck & Co.                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 F. Hoffmann-La Roche AG                    

                8.3 Eli Lilly and Company                              

                8.4 Sanofi                           

                8.5 Amgen Inc.                 

                8.6 AbbVie Inc.                 

                8.7 Biogen Idec                

                8.8 Bayer AG                     

                8.9 Johnson & Johnson Services                               

                8.10 Pfizer                          

                8.11 Novartis AG                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Bio Pharmaceuticals Market By Region, From 2016-2021 (USD Billion)
  2. Asia-Pacific Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  3. Asia-Pacific Monoclonal Antibodies (mAb) Market By Region, From 2016-2021 (USD Billion)
  4. Asia-Pacific Erythropoietin Market By Region, From 2016-2021 (USD Billion)
  5. Asia-Pacific Biotech Vaccines Market By Region, From 2016-2021 (USD Billion)
  6. Asia-Pacific Recombinant Human (RH) Insulin Market By Region, From 2016-2021 (USD Billion)
  7. Asia-Pacific Granulocyte colony-stimulating factor (G-CSF) Market By Region, From 2016-2021 (USD Billion)
  8. Asia-Pacific Interferon Market By Region, From 2016-2021 (USD Billion)
  9. Asia-Pacific Human growth hormones (HGH) Market By Region, From 2016-2021 (USD Billion)
  10. Asia-Pacific Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
  11. Asia-Pacific Neurology Market By Region, From 2016-2021 (USD Billion)
  12. Asia-Pacific Infectious diseases Market By Region, From 2016-2021 (USD Billion)
  13. Asia-Pacific Diabetes Market By Region, From 2016-2021 (USD Billion)
  14. Asia-Pacific Oncology Market By Region, From 2016-2021 (USD Billion)
  15. Asia-Pacific Cardiovascular Market By Region, From 2016-2021 (USD Billion)
  16. Asia-Pacific Other Therapeutic Areas Market By Region, From 2016-2021 (USD Billion)
  17. China Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  18. China Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
  19. India Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  20. India Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
  21. Japan Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  22. Japan Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
  23. South Korea Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  24. South Korea Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
  25. Australia Bio Pharmaceuticals Market By Product Type, From 2016-2021 (USD Billion)
  26. Australia Bio Pharmaceuticals Market By Therapeutic Type, From 2016-2021 (USD Billion)
Middle East And Africa Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Applic...
Latin America Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Re...
Asia Pacific Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Res...
Europe Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research ...
North America Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Re...
Radioimmunoassay Market By Type (Reagents And Kits Market, Analysers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research And Cli...
Middle East And Africa Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, G...
Latin America Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric El...
Asia Pacific Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Ele...
Europe Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrica...
North America Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric El...
Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrical Stimu...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.